Advanced search
Publication Cover
Cancer Investigation Volume 29, 2011 - Issue 1
Submit an article Journal homepage
151
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE: IMAGING, DIAGNOSIS, PROGNOSIS

Prognostic Value of E-Cadherin Expression and CDH1 Promoter Methylation in Patients With Endometrial Carcinoma

Tie-Zhong YiDepartment of Obstetrics and Gynecology, the First Affiliated Hospital, Harbin Medical University, Harbin, China, Department of Obstetrics and Gynecology, Qiqihaer Jianhua Hospital, Qiqihaer, China, Department of Obstetrics and Gynecology, Heilongjiang Provincal Hospital, Harbin, China, Department of Obstetrics and Gynecology, Taizhou Hospital, Zhejiang, China, Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China, Department of Obstetrics and Gynecology, Tianjin First Central Hospital, Tianjin, China
,
Jing GuoDepartment of Obstetrics and Gynecology, the First Affiliated Hospital, Harbin Medical University, Harbin, China, Department of Obstetrics and Gynecology, Qiqihaer Jianhua Hospital, Qiqihaer, China, Department of Obstetrics and Gynecology, Heilongjiang Provincal Hospital, Harbin, China, Department of Obstetrics and Gynecology, Taizhou Hospital, Zhejiang, China, Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China, Department of Obstetrics and Gynecology, Tianjin First Central Hospital, Tianjin, China
,
Lili ZhouDepartment of Obstetrics and Gynecology, the First Affiliated Hospital, Harbin Medical University, Harbin, China, Department of Obstetrics and Gynecology, Qiqihaer Jianhua Hospital, Qiqihaer, China, Department of Obstetrics and Gynecology, Heilongjiang Provincal Hospital, Harbin, China, Department of Obstetrics and Gynecology, Taizhou Hospital, Zhejiang, China, Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China, Department of Obstetrics and Gynecology, Tianjin First Central Hospital, Tianjin, China
,
Xing ChenDepartment of Obstetrics and Gynecology, the First Affiliated Hospital, Harbin Medical University, Harbin, China, Department of Obstetrics and Gynecology, Qiqihaer Jianhua Hospital, Qiqihaer, China, Department of Obstetrics and Gynecology, Heilongjiang Provincal Hospital, Harbin, China, Department of Obstetrics and Gynecology, Taizhou Hospital, Zhejiang, China, Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China, Department of Obstetrics and Gynecology, Tianjin First Central Hospital, Tianjin, China
,
Ruo-Ran MiDepartment of Obstetrics and Gynecology, the First Affiliated Hospital, Harbin Medical University, Harbin, China, Department of Obstetrics and Gynecology, Qiqihaer Jianhua Hospital, Qiqihaer, China, Department of Obstetrics and Gynecology, Heilongjiang Provincal Hospital, Harbin, China, Department of Obstetrics and Gynecology, Taizhou Hospital, Zhejiang, China, Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China, Department of Obstetrics and Gynecology, Tianjin First Central Hospital, Tianjin, China
,
Quan-Xin QuDepartment of Obstetrics and Gynecology, the First Affiliated Hospital, Harbin Medical University, Harbin, China, Department of Obstetrics and Gynecology, Qiqihaer Jianhua Hospital, Qiqihaer, China, Department of Obstetrics and Gynecology, Heilongjiang Provincal Hospital, Harbin, China, Department of Obstetrics and Gynecology, Taizhou Hospital, Zhejiang, China, Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China, Department of Obstetrics and Gynecology, Tianjin First Central Hospital, Tianjin, China
,
Jian-Hua ZhengDepartment of Obstetrics and Gynecology, the First Affiliated Hospital, Harbin Medical University, Harbin, China, Department of Obstetrics and Gynecology, Qiqihaer Jianhua Hospital, Qiqihaer, China, Department of Obstetrics and Gynecology, Heilongjiang Provincal Hospital, Harbin, China, Department of Obstetrics and Gynecology, Taizhou Hospital, Zhejiang, China, Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China, Department of Obstetrics and Gynecology, Tianjin First Central Hospital, Tianjin, China
&
Ling ZhaiDepartment of Obstetrics and Gynecology, the First Affiliated Hospital, Harbin Medical University, Harbin, China, Department of Obstetrics and Gynecology, Qiqihaer Jianhua Hospital, Qiqihaer, China, Department of Obstetrics and Gynecology, Heilongjiang Provincal Hospital, Harbin, China, Department of Obstetrics and Gynecology, Taizhou Hospital, Zhejiang, China, Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China, Department of Obstetrics and Gynecology, Tianjin First Central Hospital, Tianjin, ChinaCorrespondence[email protected]
 show all
Pages 86-92 | Published online: 27 Sep 2010

Citations (25)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Urszula Sulkowska, Andrzej Wincewicz, Luiza Kanczuga-Koda, Mariusz Koda & Stanislaw Sulkowski. (2018) Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile. Gynecological Endocrinology 34:2, pages 171-174.
Read now
Giulia Amadio, Valeria Masciullo, Maria Gabriella Ferrandina & Giovanni Scambia. (2014) Emerging drugs for endometrial cancer. Expert Opinion on Emerging Drugs 19:4, pages 497-509.
Read now
Andrea J O’Hara & Daphne W Bell. (2012) The genomics and genetics of endometrial cancer. Advances in Genomics and Genetics 2, pages 33-47.
Read now

Articles from other publishers (22)

Ting Xu, Hongmei Ding, Jie Chen, Jiahui Lei, Meng Zhao, Bingyu Ji, Youguo Chen, Songbing Qin & Qinqin Gao. (2022) Research Progress of DNA Methylation in Endometrial Cancer. Biomolecules 12:7, pages 938.
Crossref
Zahra Mohammadi, Mehdi Azad, Farshad Foroughi, Sahar Khojastehpour, Nematollah Gheibi, Fatemeh Samiee-Rad, Amirhosein Maali & MohammadHossein Ahmadi. (2021) Evaluation of expression level and methylation profile of CXX1 gene in breast cancer tissue blocks. Journal of Cancer Research and Therapeutics 17:6, pages 1328.
Crossref
Xiang Zhang, Xuecheng Pang, Yue Huang & Sumin Qian. (2021) A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma. Medicine 100:29, pages e26648.
Crossref
Burak Tatar & Sezgin Gunes. 2021. Epigenetics and Reproductive Health. Epigenetics and Reproductive Health 325 341 .
Lorenzo Ceppi, Don S. Dizon & Michael J. Birrer. 2020. Management of Endometrial Cancer. Management of Endometrial Cancer 23 47 .
Fu-Fen Yin, Li-Jun Zhao, Xiao-Yu Ji, Ning Duan, Yan-Kui Wang, Jing-Yi Zhou, Li-Hui Wei, Xiang-Jun He, Jian-Liu Wang & Xiao-Ping Li. (2019) Intra-tumor heterogeneity for endometrial cancer and its clinical significance. Chinese Medical Journal 132:13, pages 1550-1562.
Crossref
Baozhen Zhang, Jing Zhou, Zhaojun Liu, Liankun Gu, Jiafu Ji, Woo Ho Kim & Dajun Deng. (2017) Clinical and biological significance of a − 73A > C variation in the CDH1 promoter of patients with sporadic gastric carcinoma. Gastric Cancer 21:4, pages 606-616.
Crossref
Yu Fan, Yu Wang, Shaozhi Fu, Linglin Yang, Sheng Lin, Qingze Fan & Qinglian Wen. (2017) The diagnostic role of DNA methylation in sporadic endometrial cancer: a systematic review and meta-analysis. Oncotarget 9:9, pages 8642-8652.
Crossref
Carla Bartosch, José Manuel Lopes & Carmen Jerónimo. (2017) Epigenetics in endometrial carcinogenesis – part 1: DNA methylation. Epigenomics 9:5, pages 737-755.
Crossref
Sheng-Mou Hsiao, Min-Wei Chen, Chi-An Chen, Ming-Hsien Chien, Kuo-Tai Hua, Michael Hsiao, Min-Liang Kuo & Lin-Hung Wei. (2015) The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer. Annals of Surgical Oncology 22:S3, pages 1556-1565.
Crossref
Bo Zhang, XiaoYun Xing, Jing Li, Rebecca F Lowdon, Yan Zhou, Nan Lin, Baoxue Zhang, Vasavi Sundaram, Katherine B Chiappinelli, Ian S Hagemann, David G Mutch, Paul J Goodfellow & Ting Wang. (2014) Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers. BMC Genomics 15:1.
Crossref
H. M. J. Werner & H. B. Salvesen. (2014) Current Status of Molecular Biomarkers in Endometrial Cancer. Current Oncology Reports 16:9.
Crossref
Kouji Banno, Megumi Yanokura, Miho Iida, Kenta Masuda & Daisuke Aoki. (2014) Carcinogenic mechanisms of endometrial cancer: Involvement of genetics and epigenetics. Journal of Obstetrics and Gynaecology Research 40:8, pages 1957-1967.
Crossref
ELŻBIETA PŁUCIENNIK, KATARZYNA KOŒLA, KATARZYNA WÓJCIK-KROWIRANDA, ANDRZEJ BIEŃKIEWICZ & ANDRZEJ K. BEDNAREK. (2013) The WWOX tumor suppressor gene in endometrial adenocarcinoma. International Journal of Molecular Medicine 32:6, pages 1458-1464.
Crossref
Roman Fiolka. (2013) Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer. Oncology Reports.
Crossref
Peixin Dong, Masanori Kaneuchi, Yosuke Konno, Hidemichi Watari, Satoko Sudo & Noriaki Sakuragi. (2013) Emerging Therapeutic Biomarkers in Endometrial Cancer. BioMed Research International 2013, pages 1-11.
Crossref
M. Angeles López-García, Begoña Vieites, M. Angeles Castilla, Laura Romero-Pérez, Juan Díaz-Martín, Michele Biscuola & José Palacios. 2013. Cancer Genomics. Cancer Genomics 349 390 .
Kouji BannoIori Kisu, Megumi Yanokura, Kenta Masuda, Arisa Ueki, Yusuke Kobayashi, Nobuyuki Susumu & Daisuke Aoki. (2012) Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice. Epigenomics 4:2, pages 147-162.
Crossref
Meral Koyuncuoglu, Emre Okyay, Bahadir Saatli, Safak Olgan, Mustafa Akin & Ugur Saygili. (2012) Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer?. Gynecologic Oncology 125:1, pages 208-213.
Crossref
Tie-Zhong Yi, Jia Li, Xu Han, Jing Guo, Quanxin Qu, Lei Guo, Hai-Di Sun & Wen-Hua Tan. (2012) DNMT Inhibitors and HDAC Inhibitors Regulate E-Cadherin and Bcl-2 Expression in Endometrial Carcinoma in vitro and in vivo. Chemotherapy 58:1, pages 19-29.
Crossref
Kouji Banno, Iori Kisu, Megumi Yanokura, Kenta Masuda, Yusuke Kobayashi, Arisa Ueki, Kosuke Tsuji, Wataru Yamagami, Hiroyuki Nomura, Nobuyuki Susumu & Daisuke Aoki. (2012) Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics. Biochemistry Research International 2012, pages 1-5.
Crossref
Asuka Ono, Iori Kisu, Kouji Banno, Megumi Yanokura, Kenta Masuda, Yusuke Kobayashi, Kosuke Tsuji, Arisa Ueki, Wataru Yamagami, Hiroyuki Nomura, Nobuyuki Susumu & Daisuke Aoki. (2011) Epigenetic Aberrant Hypermethylation of DNA in Endometrial Cancer: Application as a Biomarker. Journal of Cancer Therapy 02:05, pages 610-615.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.